A newly identified COVID-19 lineage, officially known as BA.3.2 and informally nicknamed “Cicada,” is drawing attention from global health authorities, including the U.S. Centers for Disease Control and Prevention (CDC).

🔍 What is the “Cicada” variant?

BA.3.2 is part of the Omicron family of coronavirus variants. It was first detected in South Africa in late 2024 and later identified in multiple countries, including the United States and across Europe. 

The nickname “Cicada” comes from its unusual pattern—after initially appearing, the variant remained relatively dormant before resurfacing and spreading again in late 2025. 

🌍 Global spread and current status

• The variant has now been detected in over 20 countries. 

• It has appeared in multiple U.S. states through clinical samples and wastewater surveillance. 

• In parts of Europe (like Germany and the Netherlands), it has accounted for a significant share of cases in recent months.

Despite this spread, BA.3.2 is still considered a minority strain globally and has not yet become dominant. 

🧬 Why scientists are concerned

The “Cicada” variant stands out بسبب its high number of mutations—around 70 to 75 in the spike protein. 

These mutations may:

• Help the virus partially evade immunity from vaccines or prior infection

• Increase the chances of reinfection

• Affect how easily it spreads

However, experts emphasize that this is still being studied, and conclusions are not final.

⚠️ Severity and symptoms

So far, there is no strong evidence that BA.3.2 causes more severe illness than previous variants. 

Common symptoms remain similar to earlier Omicron strains, including:

• Sore throat

• Cough

• Fatigue

• Fever and body aches 

Most reported cases are mild to moderate. 

💉 Vaccines and protection

Early findings suggest the variant may reduce the effectiveness of immune protection, but vaccines are still expected to:

• Provide strong protection against severe illness and hospitalization

• Remain a key tool in managing the virus 

🏥 What health authorities are saying

• The CDC and global agencies are closely monitoring BA.3.2

• It is currently classified as a “variant under monitoring,” not a variant of concern

• Public health advice remains unchanged:

  • Stay updated on vaccinations

  • Practice hygiene

  • Use masks in high-risk settings

🧾 Bottom line

The BA.3.2 “Cicada” variant is an emerging strain with notable mutations, but it is not currently causing more severe disease or widespread outbreaks. Scientists are watching closely to determine whether it could become more significant in the coming months.